S.Res. 336Senate115th Congress (2017-2019)Passed Congress

A resolution recognizing the seriousness of Polycystic Ovary Syndrome and expressing support for the designation of the month of September 2018 as "Polycystic Ovary Syndrome Awareness Month".

Introduced November 16, 2017

AI-Generated Summary

Updated April 15, 2026 at 7:21 PM UTC

S.Res. 336 is a Senate resolution that acknowledges the seriousness of Polycystic Ovary Syndrome (PCOS) and backs the designation of September 2018 as PCOS Awareness Month. It aims to boost public and medical community awareness, improve diagnosis and care, and promote research toward better treatments and a cure. The resolution primarily affects women and girls in the United States who have PCOS, as well as healthcare providers and local governments that may support awareness activities.

Key Provisions

  • The Senate formally recognizes PCOS as a serious health issue affecting millions of women and girls in the United States.
  • It supports designating September 2018 as "Polycystic Ovary Syndrome Awareness Month".
  • The resolution sets three goals for the awareness month: raise public and professional knowledge about PCOS, improve diagnosis and treatment, and enhance quality of life for those affected.
  • It calls for more research, better treatment options, and ultimately a cure for PCOS.
  • The Senate encourages state, territorial, and local governments to back the awareness‑month initiatives.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

5 earlier actions
SenateFloor Latest Action

Resolution agreed to in Senate with amendments and an amended preamble by Unanimous Consent. (text: CR S8278)

December 21, 2017

View full timeline
SenateIntro Referral

Introduced in Senate

November 16, 2017

SenateIntro Referral

Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S7303)

November 16, 2017

SenateCommittee

Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.(consideration: CR S8278)

December 21, 2017

SenateDischarge

Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S8278)

December 21, 2017

SenateFloor

Measure laid before Senate by unanimous consent.

December 21, 2017

SenateFloor

Resolution agreed to in Senate with amendments and an amended preamble by Unanimous Consent. (text: CR S8278)

December 21, 2017

Floor Debate

1 member

What members said about S.Res. 336 on the floor

1 Republican
Mitch McConnell
Sen. Mitch McConnellR-KY · Dec 21, 2017

Mr. President, I ask unanimous consent that the Health, Education, Labor, and Pensions Committee be discharged from further consideration of S. Res. 336 and the Senate proceed to its immediate…

Bill Text

2 versions available

Reading Mode
Latest
Agreed to SenateIssued December 21, 2017

III

115th CONGRESS

1st Session

S. RES. 336

IN THE SENATE OF THE UNITED STATES

November 16, 2017

Ms. Warren (for herself, Mr. Perdue, Ms. Baldwin, Mr. Blumenthal, Mr. Booker, Mrs. Feinstein, Mr. Isakson, and Mrs. Fischer) submitted the following resolution; which was referred to the Committee on Health, Education, Labor, and Pensions

December 21, 2017

Committee discharged; considered, amended, and agreed to with an amended preamble

RESOLUTION

Recognizing the seriousness of Polycystic Ovary Syndrome and expressing support for the designation of the month of September 2018 as Polycystic Ovary Syndrome Awareness Month.

Whereas Polycystic Ovary Syndrome (referred to in this preamble as PCOS) is a common health problem among women and girls involving a hormonal imbalance;

Whereas there is no universal definition of PCOS, but researchers estimate that between 5,000,000 and 10,000,000 women in the United States are affected by PCOS;

Whereas PCOS can affect women from the onset of puberty and throughout the remainder of their lives;

Whereas the symptoms of PCOS include infertility, irregular or absent menstrual periods, acne, weight gain, thinning scalp hair, excessive facial and body hair growth, numerous small ovarian cysts, pelvic pain, and mental health problems;

Whereas women with PCOS have higher rates of psychosocial disorders, including depression, anxiety, bipolar disorder, and eating disorders, and are at greater risk for suicide;

Whereas adolescents with PCOS often are not diagnosed;

Whereas PCOS causes metabolic dysfunction and insulin resistance, and can lead to type 2 diabetes, cardiovascular disease, obstructive sleep apnea, nonalcoholic fatty liver disease, and endometrial cancer at a young adult age;

Whereas PCOS is the most common cause of female infertility;

Whereas PCOS in pregnancy is associated with increased risk of gestational diabetes, preeclampsia, pregnancy-induced hypertension, preterm delivery, cesarean delivery, miscarriage, and fetal and infant death;

Whereas women with PCOS are at increased risk of developing high blood pressure, high cholesterol, stroke, heart disease—the leading cause of death among women—and have a 4 to 7 times higher risk of experiencing a heart attack compared to women of the same age who do not have PCOS;

Whereas women with PCOS have a more than 50 percent chance of developing type 2 diabetes or prediabetes before the age of 40;

Whereas women with PCOS may be at a higher risk for breast cancer and ovarian cancer, and have a 3 times higher risk for developing endometrial cancer, compared to women who do not have PCOS;

Whereas many women in the United States with PCOS are overweight or have obesity;

Whereas an estimated 50 percent of women with PCOS are undiagnosed, and many remain undiagnosed until they experience fertility difficulties or develop type 2 diabetes or other cardiometabolic disorders;

Whereas the costs involved with the diagnosis and management of PCOS to the healthcare system of the United States is over $4,300,000,000 per year during the reproductive years of patients, which does not include the costs associated with treatment of comorbidities;

Whereas the cause of PCOS is unknown, but researchers have found strong links to significant insulin resistance, which affects up to 70 percent of women with PCOS, and genetic predisposition; and

Whereas there is no known cure for PCOS: Now, therefore, be it

That the Senate—

(1)

recognizes the seriousness of Polycystic Ovary Syndrome (referred to in this resolving clause as PCOS);

(2)

supports the goals of PCOS Awareness Month—

(A)

to increase awareness of, and education about, PCOS among the general public, women, girls, and healthcare professionals;

(B)

to improve diagnosis and treatment of PCOS; and

(C)

to improve the quality of life and outcomes for women and girls with PCOS;

(3)

recognizes the need for further research, improved treatment and care options, and a cure for PCOS;

(4)

acknowledges the struggles affecting all women and girls residing within the United States who have PCOS; and

(5)

encourages States, territories, and localities to support the goals of PCOS Awareness Month.